News
Latest update
Opium Addiction Market expected to rise – BioCorRx Inc, Delpor Inc, DemeRx Inc, Alar Pharmaceuticals, expected to drive market
Jun 09, 2023 (AB Digital via COMTEX) — The Opium Addiction market growth is driven by factors like increase in the prevalence …
Today, Daniel Cameron, Attorney General for the US State of Kentucky, announced that the State will take $42 million from its portion …
Deborah Mash is Professor of Neurology (Emeritus) and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. She …
Are Psychedelics The Solution To The Opioid Crisis? – Dr. Mark Hyman
If you or a loved one struggle with addiction, this is an episode you’re going to want to listen to. Many of …
10 Psychedelics CEOs To Pay Attention To In 2022
Source: https://www.benzinga.com/markets/cannabis/22/06/27799330/10-psychedelics-ceos-to-pay-attention-to-in-2022-1 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various …
ATAI, DemeRx pursue ‘neurochemical reset’ for addiction in $22M JV
People seeking treatment to overcome opioid addiction are often stymied by the treatment itself. Many don’t have access to drugs like methadone …
Anne Phillipi of The New Health Club presents Dr. Deborah Mash – ibogaine can make you review your life
Anne Phillipi of The New Health Club presents Dr. Deborah Mash – ibogaine can make you review your life Posted at 12:01h in Podcast by demerx …
DemeRx ‘forging ahead’ with Atai Life Sciences to dose patients in Phase 1 ibogaine clinical trial
DemeRx IB, Inc. CEO Deborah Mash joined Proactive New York to discuss the group’s joint venture with Atai Life Sciences (NASDAQ:ATAI), focused …
Source: https://www.healtheuropa.com/could-ibogaine-offer-a-revolutionary-long-term-solution-to-addiction/100635/ Derived from the iboga plant, ibogaine is a psychoactive compound that could have huge potential as a long-term solution to …
Breaking the Cycle of Opioid Dependence with ibogaine
Yale Psychedelics Science Group presents Dr. Deborah Mash – Breaking the Cycle of Opioid Dependence with ibogaine Watch full webinar:
Today’s episode features Deborah Mash, founder and CEO of DemeRx, a clinical stage company developing ibogaine therapies to treat substance use disorders. In this …
A joint venture between DemeRx and Atai Life Sciences has been cleared by the UK Medicines and Healthcare products Regulatory Agency (MHRA) …
DemeRx Receives MHRA Approval for DMX-1002 (ibogaine) to Commence Phase 1/2a Study as First Clinical Trial in Opioid Use Disorder in the UK
NEW YORK, March 10, 2021 /PRNewswire/ — DemeRx IB, Inc. (DemeRx), an atai Life Sciences (atai) platform company focused on developing ibogaine for the treatment …
MHRA green light for DemeRx’s opioid use disorder trial
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the launch of a Phase I/IIa trial of DemeRx and atai …
Atai Life Sciences Is Betting BIG On The Shift In Psychedelics To Treat Mental Illness
2020 has been a tough year for global markets and this is a trend that we have been closely following. During the …
CEO and co-founder of ATAI Life Sciences, Florian Brand explains why one psychedelic medicine might provide the key to fighting opioid addiction. …
Goop podcast: The Future of Addiction Treatment
“ibogaine made them ready for change,” says researcher Deborah Mash, PhD. Mash has been studying the effects of ibogaine since 1992. A psychedelic …
ATAI Life Sciences Announces Joint Venture with DemeRx to Develop ibogaine For Opioid Use Disorder
BERLIN and MIAMI, Jan. 24, 2020 /PRNewswire/ — ATAI Life Sciences AG (“ATAI” or the “Company”), a global biotech platform that envisions an end to mental illnesses, today announced …
INTERNATIONAL – The World Economic Forum’s billionaire audience in Davos took a break from the problem of climate change to listen to …
ibogaine Therapies: Remodelling the Addicted Brain
Ira Pastor, ideaXme exponential health ambassador and founder of Bioquark interviews Dr. Deborah Mash, Professor of Neurology and Molecular and Cellular Pharmacology at the Leonard M. Miller School …
Can a Shrub in Gabon Cure Addiction?
The United States is struggling with a staggering opioid addiction epidemic—often starting with legitimate pain pill prescriptions, and ending with full-blown abuse. …
Dr. Deborah Mash on Why Ibogaine Treatment Aftercare is Key to Treating the Roots of Addiction
When Dr. Deborah Mash met the grandfather of ibogaine treatment, Howard Lotsof, and observed first-hand the effectiveness that ibogaine had for addiction …
Heroin addicts and alcoholics have said ibogaine helped them kick addiction, so why is it illegal in the United States? Read full …
A Medicine that May Cure Drug Addiction: ibogaine
News from Kron 4, San Fransisco. Dr. Mash is one of the few scientists in the world to study ibogaine, a mild …